Larvol Delta - SPECTRA-A-Controlled-Phase-23-Study-of-Adjuvanted-Recombinant-SARSCoV2-Trimeric-Sprotein-Vaccine-SCB2019-for-the-Prevention-of-COVID19

SCB-2019 - Sichuan Clover Biopharma

adjuvant CpG 1018 - Dynavax

http://clinicaltrials.gov/ct2/show/NCT04672395

Aug 29, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next